Search

everythinglearnresearchcommunity

for

Search:↓

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Pressure from injectable treatments can cause hair loss by compressing blood vessels.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

People in palliative care often have skin problems due to their main illness or other health issues, and treatments focus on comfort and quality of life.

People with androgenetic alopecia may have a higher risk of severe COVID-19.

COVID-19 can cause skin symptoms that might help spot the virus early, and treatments for it can also affect the skin.

Erythema multiforme-like lesions can occur in lupus without drug use or herpes infection.

Hair grows in cycles and changes with age, starting from fetal development.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Hair restoration surgery has evolved over time, with a focus on natural-looking results and managing patient expectations, while also considering potential complications and the lifelong progression of male pattern baldness.

A 69-year-old man with sinus infection and fainting spells was diagnosed with a rare kidney disease, treated with steroids and a specific drug, which improved his condition.

SIG-1451 could be a promising new treatment for atopic dermatitis.

A three-year-old girl survived a rare serious infection caused by BCG vaccination, which improved after treatment with a leprosy drug.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

The document summarizes recent dermatological treatments and advances in areas like pediatric care, wound healing, skin closure, light-based therapies, pigment disorders, hair loss, immunotherapy, infection management, melanoma, drug reactions, and facial rejuvenation.

PRP injections may be an effective treatment for severe hair loss.

New injection methods for hair loss treatment show promise but need more research.

Optimal long-acting finasteride injection dose found: 16.8 mg, effective for one month.

Photothermal hydrogels are promising for infection control and tissue repair, and combining them with other treatments could improve results and lower costs.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

The collagen sponge with lincomycin heals tooth sockets faster and reduces infection better than iodoform gauze.

The best starting dose for a new finasteride injection is 16.80 mg.

Low power red laser with efavirenz can reduce HIV-1 infection to undetectable levels and improve diagnosis.

The cerium-polypeptide hydrogel effectively heals drug-resistant bacterial wounds by fighting bacteria, reducing inflammation, and promoting tissue repair.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

The hydrogel with silver and ibuprofen promotes wound healing and fights infection.